CMPS
Compass Pathways Plc
NASDAQ: CMPS · HEALTHCARE · MEDICAL CARE FACILITIES
$14.35
+0.91% today
Updated 2026-09-11
Market cap
$1.99B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$5 – $16
Volume
3.4M
WallStSmart proprietary scores
22
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.0
Quality
C3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-10.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$23.75
+65.51%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -10.28 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-40.31M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-91.50M | $-118.46M | $-155.12M | $-287.86M | $-253.79M |
| EPS | — | — | — | — | $-3.79 |
| Free cash flow | $-106.05M | $-97.44M | $-119.19M | $-157.24M | $-40.31M |
| Profit margin | — | — | — | — | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-26 | NATH, KABIR | Buy | 367,815 | — |
| 2026-03-26 | NATH, KABIR | Buy | 175,000 | — |
| 2026-03-26 | LOXAM, TERI | Buy | 157,635 | — |
Peer comparison
Smart narrative
Compass Pathways Plc trades at $14.35. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -10.28, it sits in the distress.
Frequently asked questions
What is Compass Pathways Plc's stock price?
Compass Pathways Plc (CMPS) trades at $14.35.
Is Compass Pathways Plc overvalued?
Compass Pathways Plc carries a Smart Value Score of 22/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Compass Pathways Plc (CMPS)?
The 12-month analyst consensus target is $23.75, about 65.5% above the current $14.35. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Compass Pathways Plc's Altman Z-Score is -10.28, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-54.78%
Beta2.55
50D MA$13.13
200D MA$9.35
Shares out0.14B
Float0.11B
Short ratio—
Avg volume3.4M
Performance
1 week+64.52%
1 month+74.86%
3 months+29.41%
YTD+37.10%
1 year—
3 years—
5 years—